Skip over navigation
Banner
Industry
Directory Facilities Technology Transfer Economic Develop. AB BioHistory (TM)
Career
Job Search Post a Job Destination AB
News/Events
Industry News Submit News Release Calendar Submit Event CEO Reading
Patient
Clinical Trials Drug Development Resources
Education
K-12 Higher Ed BioEd Reading
About
Advertising Feedback Home
 
About
 Advertising
 Feedback
 Home
Quick Links
 Directory
 Job Search
 Facilities
 Calendar
 Advertising
Community Service Ad: National Center for Missing & Exploited Children
Events
 
Facilities
 

ORCA Monthly Meeting: March 16 - Requirements & Best Practices for Management Review

Conference on Biosimilars, University of Washington, Seattle - March 19-20. Sign up today!



BioHistory Moment: Iditarod Trail used to transport diphtheria serum to Nome.

Balto

In 1925, a life-or-death race to save the children of Nome from a diphtheria epidemic made an international hero of one sled dog, and led to the creation of Alaska's Iditarod sled dog race. A diphtheria epidemic threatened remotely located Nome, and air transportation was unavailable to transport serum from Anchorage nearly a thousand miles away.

The solution: A relay of dog teams transported serum on the Iditarod Trail from Nenana to Nome, and every village enroute provided its best team and driver for the next leg continually moving the serum toward Nome. Gunnar Kaasen, a Norwegian musher, drove the final two legs into Nome behind his lead dog Balto through a blizzard with 80 mph winds to deliver 300,000 units of diphtheria antitoxin to Dr. Curtis Welch, the only doctor in Nome.

The serum arrived in time, prevented the epidemic and saved hundreds of lives. The 20 mushers had covered nearly 700 miles in slightly more than 127 hours in temperatures of minus40° Fahrenheit below zero and strong winds. The serum run received worldwide press coverage and the mushers received special gold medals and other recognition. In 1926, a statue of Balto, the heroic lead dog, was erected in New York's Central Park.

More...

Learn about Seattle's PNDRI Life Sciences Incubator Building

PNDRI Sciences Incubator Building, Seattle, WA. A contemporary-designed building provided with modern research systems. Four floors are specifically laboratory space, one floor is a fully equipped vivarium and one floor is clinical space and management offices.

Learn about biotechnology, medical device and pharmaceutical facilities available for sale, lease or sublease in Alberta, regionally or nationwide.

More...

(Advertising)


Industry News...

    Free News Release Posting & Archiving Service


  • A. Bruce Montgomery, M.D., joins ZymoGenetics board of directors  ZymoGenetics announced that A. Bruce Montgomery, M.D., was named to the company's Board of Directors. Dr. Montgomery serves as Senior Vice President and Head of Respiratory Therapeutics at Gilead Sciences, and previously founded Corus Pharma.
    ZymoGenetics, Inc.  March 11, 2010  


  • Seattle Genetics expands antibody-drug conjugate patent Portfolio  Seattle Genetics announced that the U.S. PTO has issued a patent related to its antibody-drug conjugate ADC technology. U.S. Patent No. 7,659,241 covers cleavable linkers and potent auristatin drug payloads used in certain of Seattle Genetics' ADC programs, most notably brentuximab vedotin.
    Seattle Genetics, Inc.  March 11, 2010  


  • CombiMatrix Corporation reports fourth quarter 2009 financial results  Revenues for the fourth quarter of 2009 were $1.1 million versus $970,000 for the third quarter of 2009 and $1.2 million in the fourth quarter of 2008.
    CombiMatrix Corporation  March 10, 2010  


  • Monsanto ranks no. 28 on the 2010 DiversityInc Top 50 Companies for Diversity(R) list  Monsanto Company has been named to The 2010 DiversityInc Top 50 Companies for Diversity(R) list for its demonstrated use of measurable diversity best practices and results. A total of 449 companies participated this year, up 12 percent from last year.
    Monsanto Company  March 10, 2010  


  • QLT announces fourth quarter and year end 2009 results  QLT sold its subsidiary, QLT USA, including its Eligard(R) line of products, on October 1, 2009. The Company was paid $20 million on closing, and will receive $10 million on October 1, 2010 and up to an additional $200 million in quarterly payments.
    QLT, Inc.  March 10, 2010  


More... | Submit News Release | Advertising...

News

New Job Postings...

Free Job Posting Trial Offer
  • Research Associate I - Bench, Center for Integrative Brain Research Seattle Children's Hospital (WA)
  • Postdoctoral Fellow, Computational Biology Institute for Systems Biology (WA)
  • Scientist/Senior Scientist, Formulations Seattle Genetics, Inc. (WA)
  • Quality Assurance Validation Associate Seattle Genetics, Inc. (WA)
  • Quality Assurance Manufacturing Associate Seattle Genetics, Inc. (WA)
More... | Job Advertising... | About Job Postings...
Master's Degree in Biomedical Regulatory Affairs

New Facilities Available...

ATC clean room constructors...validation guaranteed!
  • 890 Embarcadero Road Property -- West Sacramento, CA
  • CompleGen Lab/Office Space -- Seattle, WA
  • Life Sciences Incubator -- Seattle, WA
  • University of Iowa Oakdale Research Park Biotech Building -- Coralville, IA
  • University of Iowa Oakdale Research Park BioVentures Center -- Coralville, IA
More... | Facility Advertising...
Facilities

Upcoming Events...

  • 03/11/2010: Vlab: Smart Approaches to IPR: Tips and Warnings from Those in the Know
  • 03/11/2010: Bagels at BIOCOM
  • 03/11/2010: Online Webinar: Performing Investigations for Environment
  • 03/11/2010: Online Webinar: Environmental Excursion Investigations
  • 03/12/2010: Are You Ready for the Changes to the Medical Device Directive
More... | Submit Event | Event Advertising...
Master's Degree in Biomedical Regulatory Affairs

Learn About Alberta's BioHistory

Learn About Alberta's BioHistory Why is there a life science industry in Alberta? Is the industry growing? What do other states have?

Through Alberta BioHistory, you can learn about the scientists, institutions, political leaders, and significant events that have shaped and are still shaping the biotechnology, medical device and life science industry in Alberta.

More...

BioEvolution Posters

WA BioEvolution 2008 Poster

More More...


March - National Colorectal Cancer Awareness Month

National Colorectal Cancer Awareness Month

As a leading health organization for 25 years, the Prevent Cancer Foundation, the vision of Carolyn Aldigé, has catapulted cancer prevention to prominence and provided more than $113 million in support of cancer prevention and early detection research, education and community outreach programs across the country.

More...


BioFact

(1923) - More than 50,000 foreign plants have been introduced into the United States since 1862 by the USDA. Along with these plants came 90% of the pests that plague agriculture today; most are invisible microbes.


It's a Small World

  Measles Virus Measles Virus  

Science Quote

"What drugs will not cure, the knife will; what the knife will not cure, the cautery will; what the cautery will not cure must be considered incurable. "

-  Hippocrates, Greek physician
 (c. 460-377 BC)

 
Email thie page to a friend. Email This Page
to a Friend
Print this page. Print This
Page
© 2010 Info.Resource, Inc. All rights reserved.
Privacy Policy . Terms of Use . Advisory Board . Advertising

AlbertaLifeScience.com, owned and published by Info.Resource, Inc., is a resource
for the life science industry in the province of Alberta.